Whitehawk Therapeutics, Inc. (WHWK) stock
WHWKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$3.08+0.07 (+2.33%)
Close on Nov 17, 2026Market cap $175.59MP/E –Yield –
Whitehawk Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Whitehawk Therapeutics's operating margin for the twelve months ending Dec 31, 2025 was -1601.1%. For fiscal 2025 it was -1601.1%, against -259.6% the year before. The highest annual figure on record is -18.2% in fiscal 2020.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1601.1% | −1341.5 |
| FY2024 | Dec 31, 2024 | -259.6% | +35.7 |
| FY2023 | Dec 31, 2023 | -295.4% | +116.6 |
| FY2022 | Dec 31, 2022 | -411.9% | +382.5 |
| FY2021 | Dec 31, 2021 | -794.4% | −776.2 |
| FY2020 | Dec 31, 2020 | -18.2% | +37.3 |
| FY2018 | Dec 31, 2018 | -55.5% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2025 | Mar 31, 2025 | -213.0% | +151.5 |
| Q4 FY2024 | Dec 31, 2024 | -261.8% | +18.3 |
| Q3 FY2024 | Sep 30, 2024 | -186.0% | +113.5 |
| Q2 FY2024 | Jun 30, 2024 | -252.2% | +62.9 |
| Q1 FY2024 | Mar 31, 2024 | -364.5% | −77.7 |
| Q4 FY2023 | Dec 31, 2023 | -280.0% | +16.0 |
| Q3 FY2023 | Sep 30, 2023 | -299.5% | +54.7 |
| Q2 FY2023 | Jun 30, 2023 | -315.1% | +219.0 |
| Q1 FY2023 | Mar 31, 2023 | -286.8% | +312.0 |
| Q4 FY2022 | Dec 31, 2022 | -296.0% | −181.1 |
| Q3 FY2022 | Sep 30, 2022 | -354.2% | +3051.6 |
| Q2 FY2022 | Jun 30, 2022 | -534.2% | −596.1 |
| Q1 FY2022 | Mar 31, 2022 | -598.8% | +554.0 |
| Q4 FY2021 | Dec 31, 2021 | -114.9% | −176.6 |
| Q1 FY2021 | Mar 31, 2021 | -3405.8% | +410128.6 |
| Q4 FY2020 | Dec 31, 2020 | 61.9% | +2.4 |
| Q3 FY2020 | Sep 30, 2020 | -1152.8% | −700.1 |
| Q2 FY2020 | Jun 30, 2020 | 61.7% | – |
| Q4 FY2018 | Dec 31, 2018 | -413534.4% | – |
| Q3 FY2018 | Sep 30, 2018 | 59.5% | – |
| Q2 FY2018 | Jun 30, 2018 | -452.7% | – |
See a number that looks wrong?